BALM3 Stock Overview

Engages in the development, industrialization, trade, production, import, export, and technical assistance in products for hospitals and industries related to the health area and for orthopedic and dental surgeries in Brazil. More details

BALM3 fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	0/6
Past Performance	5/6
Financial Health	6/6
Dividends	4/6

Rewards

Trading at 70.7% below our estimate of its fair value

Earnings grew by 243.9% over the past year

Risk Analysis

Shares are highly illiquid

Unstable dividend track record

Does not have a meaningful market cap (R$146M)

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Baumer S.A. Competitors

S.C. IOR

BVB:IORB

RON 109.9m

Sincere

TSE:7782

JP¥4.5b

Yash Optics & Lens

NSEI:YASHOPTICS

₹2.0b

Qualicorp Consultoria e Corretora de Seguros

BOVESPA:QUAL3

R$590.8m

Price History & Performance

Summary of share price highs, lows and changes for Baumer
Historical stock prices
Current Share Price	R$15.50
52 Week High	R$19.00
52 Week Low	R$9.90
Beta	0.37
1 Month Change	-5.78%
3 Month Change	0%
1 Year Change	37.90%
3 Year Change	3.33%
5 Year Change	34.78%
Change since IPO	518.76%

Recent updates

Shareholder Returns

	BALM3	BR Medical Equipment	BR Market
7D	10.4%	1.9%	-0.6%
1Y	37.9%	4.0%	-1.0%

Return vs Industry: BALM3 exceeded the BR Medical Equipment industry which returned 4% over the past year.

Return vs Market: BALM3 exceeded the BR Market which returned -1% over the past year.

Price Volatility

Is BALM3's price volatile compared to industry and market?
BALM3 volatility
BALM3 Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	7.0%
Market Average Movement	5.0%
10% most volatile stocks in BR Market	9.6%
10% least volatile stocks in BR Market	2.7%

Stable Share Price: BALM3's share price has been volatile over the past 3 months compared to the BR market.

Volatility Over Time: Insufficient data to determine BALM3's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1952	n/a	Ruy Salvari Baumer	www.baumer.com.br

Baumer S.A. engages in the development, industrialization, trade, production, import, export, and technical assistance in products for hospitals and industries related to the health area and for orthopedic and dental surgeries in Brazil. The company offers drugs for bone regeneration, including membrane and graft; and equipment for safe environment, disinfection, preparing and inspecting, water treatment, sterilization, transfer, storage, transport, surgical room, and cleaning. It also provides orthopedic devices, such as conventional prosthesis, non-conventional prosthesis, trauma, neurosurgery, and bone cement.

Baumer S.A. Fundamentals Summary

How do Baumer's earnings and revenue compare to its market cap?
BALM3 fundamental statistics
Market cap	R$146.27m
Earnings (TTM)	R$31.61m
Revenue (TTM)	R$194.39m

4.5x

P/E Ratio

0.7x

P/S Ratio

Is BALM3 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BALM3 income statement (TTM)
Revenue	R$194.39m
Cost of Revenue	R$74.58m
Gross Profit	R$119.81m
Other Expenses	R$88.20m
Earnings	R$31.61m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	3.23
Gross Margin	61.63%
Net Profit Margin	16.26%
Debt/Equity Ratio	9.6%

How did BALM3 perform over the long term?

See historical performance and comparison

Dividends

5.0%

Current Dividend Yield

22%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/05 14:53
End of Day Share Price	2025/05/02 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Baumer S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Baumer BOVESPA:BALM3 Stock Report